CenterBook Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
CenterBook Partners's BMY Position: Q2 2026 in Review
CenterBook Partners increased its Bristol-Myers Squibb (BMY) stake by 3.3% in Q2 2026, buying an estimated $107K and bringing the position to 58,208 shares worth $3.35M. The position accounts for 0.16% of the portfolio, ranked #146.
CenterBook Partners first reported a position in BMY in Q1 2023 and has held it in 5 quarters since. The position peaked at $3.42M in Q1 2026. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- CenterBook Partners held 58,208 shares of Bristol-Myers Squibb worth $3.35M as of Q2 2026.
- CenterBook Partners bought 1,868 Bristol-Myers Squibb shares in Q2 2026, an estimated $107K.
- Bristol-Myers Squibb made up 0.16% of CenterBook Partners's portfolio in Q2 2026, its #146 holding.
- CenterBook Partners first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 5 quarters since.
- CenterBook Partners's Bristol-Myers Squibb position peaked at $3.42M in Q1 2026.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.